Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT
Calidi Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 1.5M | 1.5M | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.19M | 1.16M | 1.14M | 1.51M | 1.22M | 838K | 464K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -439K | -410K | -390K | -1.51M | -1.22M | -838K | -464K | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -19.98M | -20.09M | -21.78M | -27.57M | -29.57M | -25.29M | -20.57M | -13.46M | -7.3M | -6.17M | -4.67M | -2.56M | -2.59M | -2.24M | -1.71M | -1.1M | -10K |
Interest Income | n/a | n/a | n/a | n/a | n/a | 493.56K | 493.56K | 493.56K | 493.56K | 160K | 176.5K | 176.5K | 176.5K | 16.5K | n/a | n/a | n/a |
Pretax Income | -20.03M | -20.03M | -22.2M | -26.28M | -23.23M | -21.66M | -16.59M | -10.81M | -8.1M | 255.92K | 3.88M | 10.61M | 9.09M | 4.92M | 3.46M | -833.29K | -10K |
Net Income | -19.85M | -19.9M | -22.14M | -26.27M | -23.25M | -29.98M | -29.22M | -28.74M | -32.07M | -15.41M | -7.49M | -3.22M | 1.31M | -2.86M | -4.32M | -833.29K | -10K |
Selling & General & Admin | 10.99M | 11.53M | 12.52M | 15.81M | 16.61M | 14.5M | 12.89M | 10.11M | 7.3M | 6.17M | 4.67M | 2.56M | 2.59M | 2.24M | 1.71M | 1.1M | 10K |
Research & Development | 8.99M | 8.56M | 8.88M | 11.02M | 12.12M | 13.13M | 13.01M | 11.31M | 10.01M | 6.83M | 4.21M | 1.95M | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -16K | -21K | -34K | -34K | -18K | -13K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 19.98M | 20.09M | 21.4M | 26.83M | 28.73M | 24.45M | 20.1M | 13.36M | 7.3M | 6.17M | 4.67M | 2.56M | 2.59M | 2.24M | 1.71M | 1.1M | 10K |
Interest Expense | 531K | 752K | 933K | 980K | 1.07M | 1.1M | 1.07M | 945K | 650K | 344K | 127K | 91K | 62K | 62K | 62K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -374K | -738K | -838K | -2.7M | -3.09M | -2.44M | -4.41M | -2.55M | -1.79M | -2.08M | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.98M | 20.09M | 21.78M | 27.57M | 29.57M | 25.29M | 20.57M | 13.46M | 7.3M | 6.17M | 4.67M | 2.56M | 2.59M | 2.24M | 1.71M | 1.1M | 10K |
Income Tax Expense | 11K | 15K | 16K | 10K | 20K | 89.95K | 151.42K | 297.72K | 490.41K | 412.46K | 346.99K | 203.69K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.88M | 2.25M | 664.41K | 649.39K | 442.22K | 295.08K | 294.83K | 118.77K | 81.99K | 81.99K | 81.99K | 219.9K | 238.63K | 238.63K | 238.63K | 238.63K | 238.63K |
Shares Outstanding (Diluted) | 2.88M | 2.25M | 664.41K | 649.39K | 442.22K | 295.08K | 294.83K | 118.77K | 81.99K | 81.99K | 81.99K | 219.9K | 238.63K | 238.63K | 238.63K | 238.63K | 238.63K |
EPS (Basic) | -14.37 | -29.18 | -51.39 | -76.82 | -85.99 | -121.03 | -123.61 | -127.25 | -108 | -38.76 | -5.64 | 43.68 | 37.92 | 20.48 | 14.36 | -3.52 | -0.04 |
EPS (Diluted) | -14.37 | -29.18 | -51.39 | -76.82 | -85.99 | -121.03 | -123.61 | -127.25 | -108 | -38.76 | -5.64 | 43.68 | 37.92 | 20.48 | 14.36 | -3.52 | -0.04 |
EBITDA | -18.28M | -17.73M | -19.73M | -23.8M | -20.69M | -17.08M | -15.81M | -16.95M | -20.93M | -19.8M | -15.01M | -9M | -4.77M | -4.42M | -3.89M | -1.1M | -10K |
EBIT | -19.5M | -19.28M | -21.26M | -25.3M | -22.15M | -20.84M | -20.11M | -19.76M | -23.4M | -15.07M | -7.36M | -3.13M | 1.38M | -2.8M | -4.26M | -833.29K | -10K |
Depreciation & Amortization | 1.58M | 1.55M | 1.53M | 1.51M | 1.46M | 1.45M | 1.26M | 983K | 700K | 336K | 153K | 62K | n/a | n/a | n/a | n/a | n/a |